255 related articles for article (PubMed ID: 35389061)
1. [Multiparametric MRI of the prostate].
Herrmann J; Kaufmann S; Zhang C; Rausch S; Bedke J; Stenzl A; Nikolaou K; Kruck S; Seith F
Urologe A; 2022 Apr; 61(4):428-440. PubMed ID: 35389061
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
4. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
[TBL] [Abstract][Full Text] [Related]
5. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
[TBL] [Abstract][Full Text] [Related]
6. [Multiparametric MRI of the prostate: requirements and principles regarding diagnostic reporting].
Ursprung S; Herrmann J; Nikolaou K; Harland N; Bedke J; Seith F; Zinsser D
Urologie; 2023 May; 62(5):449-458. PubMed ID: 36941383
[TBL] [Abstract][Full Text] [Related]
7. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
[TBL] [Abstract][Full Text] [Related]
8. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
[TBL] [Abstract][Full Text] [Related]
10. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
11. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
Junker D; Steinkohl F; Fritz V; Bektic J; Tokas T; Aigner F; Herrmann TRW; Rieger M; Nagele U
World J Urol; 2019 Apr; 37(4):691-699. PubMed ID: 30078170
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
[TBL] [Abstract][Full Text] [Related]
13. Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?
Kim H; Pak S; Park KJ; Kim MH; Kim JK; Kim M; You D; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Clin Genitourin Cancer; 2020 Feb; 18(1):50-55. PubMed ID: 31640913
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.
De Visschere PJ; Vral A; Perletti G; Pattyn E; Praet M; Magri V; Villeirs GM
Eur Radiol; 2017 May; 27(5):2095-2109. PubMed ID: 27491874
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?
Antunes N; Vas D; Sebastia C; Salvador R; Ribal MJ; Nicolau C
Abdom Radiol (NY); 2021 Jul; 46(7):3401-3409. PubMed ID: 33683430
[TBL] [Abstract][Full Text] [Related]
16. Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting.
Raeside M; Low A; Cohen P; Sutherland P; Gormly K
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):487-494. PubMed ID: 30951248
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
[TBL] [Abstract][Full Text] [Related]
19. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
